溶小體酸性解脂酵素的全球市場:產業分析，規模，佔有率，成長，趨勢，及預測(2022年～2028年)

本報告提供全球溶小體酸性解脂酵素市場調查，提供市場概要，市場規模和預測，趨勢，成長要素及阻礙因素，適應症·治療層級·各地區等的分析，再加上企業簡介等資訊。

目錄

第1章 序文

第2章 摘要整理

第3章 溶小體酸性解脂酵素:產業分析

• 簡介:市場動態
• 推動市場要素
• 阻礙市場要素
• 市場機會
• 產業趨勢
• 波特的五力分析
• 市場魅力分析

第4章 價值鏈分析

• 價值鏈分析
• 原料分析
• 潛在的買主清單
• 行銷流通管道

第5章 COVID-19發生的影響分析

• COVID-19發生的影響分析
• COVID-19對生產，進口，出口及需求的影響分析
• 市場:COVID-19前vsCOVID-1後
• COVID-19疫情的影響估計
• COVID-19:微觀及宏觀因素分析

第6章 全球溶小體酸性解脂酵素市場分析:各適應症

• 各適應症概要
• 實際成果資料與預測資料
• 各適應症分析
• 各地區的Wolman Disease(WD)市場
• 各地區的Cholesteryl Ester Storage Disease(CESD)市場

第7章 全球溶小體酸性解脂酵素市場分析:各治療層級

• 各治療層級概要
• 實際成果資料與預測資料
• 各治療層級分析
• 各地區的酵素補充療法市場
• 各地區的脂質修飾劑(Statin)市場
• 各地區的外科(肝臟移植)市場
• 各地區的幹細胞移植市場
• 各地區的支援照護市場

第8章 全球溶小體酸性解脂酵素市場分析:各地區

• 地區預測
• 簡介
• 北美
• 歐洲
• 亞太地區
• 南美
• 中東·非洲

第9章 溶小體酸性解脂酵素企業的競爭情形

• 溶小體酸性解脂酵素市場競爭
• 夥伴關係/合作/契約
• 合併和收購
• 新產品的銷售
• 其他的開發

第10章 企業簡介

• 企業佔有率分析
• 市場集中度
• AstraZeneca plc.
• Alexion Pharmaceutical Inc.
• Pfizer
• Merck &Co., Inc.
• Pfizer, Inc.
• Teva Pharmaceutical Industries Ltd

Value Market Research deeply researched the Global Lysosomal Acid Lipase Market to foresee a significant growth in the industry over the upcoming years. The global lysosomal acid lipase market report provides a complete industry analysis, market size, market share, growth trends, and forecasts for 2023 to 2028. The report starts with a detailed market introduction and an executive summary that highlights the report's key growth numbers. The subsequent chapters discuss the value chain of the market, Porter's Five Forces Model, and market attractiveness analysis. An exclusive chapter on COVID-19 impact analysis has been added to understand how the market has responded to the pandemic.

The market dynamics section of the report elaborates the current market drivers, restraints along with the challenges/risks and upcoming opportunities. This section can be of high interest for any company's strategists and new product development department. The global lysosomal acid lipase market study segments the market and provides the market size in terms of revenue and/ or sales. This data is bifurcated by region and later by countries. The data is collected through detailed primary interviews and industry experts across the world. The detailed methodology can be seen in our sample reports. These market estimates are also influenced by the latest social, political and economic changes along with the current market dynamics that are affecting this lysosomal acid lipase market.

The next sections of the lysosomal acid lipase market report studies the market competitiveness and profiles some key market players/manufacturers. These sections are knowledgeable for understanding the competitor's product-line, their financials, recent developments and the top market share owners in the industry.

Countries Covered in the report are as below:

North America - United States, Canada, and Mexico

Europe - United Kingdom, Germany, France, Italy, Russia, Spain & Rest of Europe

Asia-Pacific - China, India, Japan, South Korea, Australia & Rest of APAC

Latin America - Brazil, Argentina, Peru, Chile & Rest of Latin America

Middle East and Africa - Saudi Arabia, UAE, Israel, South Africa

Market Segmentation in the report is as below-

By Indication

Wolman Disease (WD)

Cholesteryl Ester Storage Disease (CESD)

By Treatment Class

Enzyme Replacement Therapy

Lipid-Modifying Agents (Statins)

Surgery (Liver Transplant)

Stem Cell Transplantation

Supportive Care

TABLE OF CONTENTS

1 . PREFACE

• 1.1. Report Description
  • 1.1.1. Objective
  • 1.1.2. Target Audience
  • 1.1.3. Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1. Market Research Process
  • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3 . LYSOSOMAL ACID LIPASE - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 By Indication
  • 3.7.2 By Treatment Class
  • 3.7.3 By Region

4 . VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1. List of Raw Materials
  • 4.2.2. Raw Material Manufactures List
  • 4.2.3. Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1. Direct Marketing
  • 4.4.2. Indirect Marketing
  • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

• 5.1. Impact Analysis of Covid-19 Outbreak
  • 5.1.1. Direct Impact on Production
  • 5.1.2. Supply Chain and Market Disruption
  • 5.1.3. Financial Impact on Firms and Financial Markets
• 5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
• 5.3. Market: Pre V/S Post COVID-19
• 5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic
• 5.5. COVID-19: Micro and Macro Factor Analysis

6 . GLOBAL LYSOSOMAL ACID LIPASE MARKET ANALYSIS BY INDICATION

• 6.1 Overview by Indication
• 6.2 Historical and Forecast Data
• 6.3 Analysis by Indication
• 6.4 Wolman Disease (WD) Market by Regions
• 6.6 Cholesteryl Ester Storage Disease (CESD) Market by Regions

7 . GLOBAL LYSOSOMAL ACID LIPASE MARKET ANALYSIS BY TREATMENT CLASS

• 7.1 Overview by Treatment Class
• 7.2 Historical and Forecast Data
• 7.3 Analysis by Treatment Class
• 7.4 Enzyme Replacement Therapy Market by Regions
• 7.5 Lipid-Modifying Agents (Statins) Market by Regions
• 7.6 Surgery (Liver Transplant) Market by Regions
• 7.7 Stem Cell Transplantation Market by Regions
• 7.8 Supportive Care Market by Regions

8 . GLOBAL LYSOSOMAL ACID LIPASE MARKET ANALYSIS BY GEOGRAPHY

• 8.1. Regional Outlook
• 8.2. Introduction
• 8.3. North America
  • 8.3.1. Overview, Historic and Forecast Data
  • 8.3.2. North America By Segment
  • 8.3.3. North America By Country
  • 8.3.4. United State
  • 8.3.5. Canada
  • 8.3.6. Mexico
• 8.4. Europe
  • 8.4.1. Overview, Historic and Forecast Data
  • 8.4.2. Europe by Segment
  • 8.4.3. Europe by Country
  • 8.4.4. United Kingdom
  • 8.4.5. France
  • 8.4.6. Germany
  • 8.4.7. Italy
  • 8.4.8. Russia
  • 8.4.9. Rest Of Europe
• 8.5. Asia Pacific
  • 8.5.1. Overview, Historic and Forecast Data
  • 8.5.2. Asia Pacific by Segment
  • 8.5.3. Asia Pacific by Country
  • 8.5.4. China
  • 8.5.5. India
  • 8.5.6. Japan
  • 8.5.7. South Korea
  • 8.5.8. Australia
  • 8.5.9. Rest Of Asia Pacific
• 8.6. Latin America
  • 8.6.1. Overview, Historic and Forecast Data
  • 8.6.2. Latin America by Segment
  • 8.6.3. Latin America by Country
  • 8.6.4. Brazil
  • 8.6.5. Argentina
  • 8.6.6. Peru
  • 8.6.7. Chile
  • 8.6.8. Rest of Latin America
• 8.7. Middle East & Africa
  • 8.7.1. Overview, Historic and Forecast Data
  • 8.7.2. Middle East & Africa by Segment
  • 8.7.3. Middle East & Africa by Country
  • 8.7.4. Saudi Arabia
  • 8.7.5. UAE
  • 8.7.6. Israel
  • 8.7.7. South Africa
  • 8.7.8. Rest Of Middle East And Africa

9 . COMPETITIVE LANDSCAPE OF THE LYSOSOMAL ACID LIPASE COMPANIES

• 9.1. Lysosomal Acid Lipase Market Competition
• 9.2. Partnership/Collaboration/Agreement
• 9.3. Merger And Acquisitions
• 9.4. New Product Launch
• 9.5. Other Developments

10 . COMPANY PROFILES OF LYSOSOMAL ACID LIPASE INDUSTRY

• 10.1. Company Share Analysis
• 10.2. Market Concentration Rate
• 10.3. AstraZeneca plc.
  • 10.3.1. Company Overview
  • 10.3.2. Financials
  • 10.3.3. Products
  • 10.3.4. Recent Developments
• 10.4. Alexion Pharmaceutical Inc.
  • 10.4.1. Company Overview
  • 10.4.2. Financials
  • 10.4.3. Products
  • 10.4.4. Recent Developments
• 10.5. Pfizer
  • 10.5.1. Company Overview
  • 10.5.2. Financials
  • 10.5.3. Products
  • 10.5.4. Recent Developments
• 10.6. Merck & Co., Inc.
  • 10.6.1. Company Overview
  • 10.6.2. Financials
  • 10.6.3. Products
  • 10.6.4. Recent Developments
• 10.7. Pfizer, Inc.
  • 10.7.1. Company Overview
  • 10.7.2. Financials
  • 10.7.3. Products
  • 10.7.4. Recent Developments
• 10.8. Teva Pharmaceutical Industries Ltd
  • 10.8.1. Company Overview
  • 10.8.2. Financials
  • 10.8.3. Products
  • 10.8.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

• Market Snapshot
• Drivers : Impact Analysis
• Restraints : Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• List of Potential Buyers
• COVID-19 Impact Analysis by Production, Import, Export and Demand
• Pre V/S Post COVID-19
• Estimated Impact Of The Coronavirus (Covid-19) Epidemic
• COVID-19: Micro and Macro Factor Analysis
• Analysis by Indication (USD MN)
• Wolman Disease (WD) Market by Geography (USD MN)
• Cholesteryl Ester Storage Disease (CESD) Market by Geography (USD MN)
• Analysis Market by Treatment Class (USD MN)
• Enzyme Replacement Therapy Market by Geography (USD MN)
• Lipid-Modifying Agents (Statins) Market by Geography (USD MN)
• Surgery (Liver Transplant) Market by Geography (USD MN)
• Stem Cell Transplantation Market by Geography (USD MN)
• Supportive Care Market by Geography (USD MN)
• Global Lysosomal Acid Lipase Market by Geography (USD MN)
• North America Market Analysis (USD MN)
• United State Market Analysis (USD MN)
• Canada Market Analysis (USD MN)
• Mexico Market Analysis (USD MN)
• Europe Market Analysis (USD MN)
• Europe Market Estimate by Country (USD MN)
• United Kingdom Market Analysis (USD MN)
• France Market Analysis (USD MN)
• Germany Market Analysis (USD MN)
• Italy Market Analysis (USD MN)
• Russia Market Analysis (USD MN)
• Spain Market Analysis (USD MN)
• Rest of Europe Market Analysis (USD MN)
• Asia Pacific Market Analysis (USD MN)
• China Market Analysis (USD MN)
• Japan Market Analysis (USD MN)
• India Market Analysis (USD MN)
• South Korea Market Analysis (USD MN)
• Australia Market Analysis (USD MN)
• Rest of Asia Pacific Market Analysis (USD MN)
• Latin America Market Analysis (USD MN)
• Brazil Market Analysis (USD MN)
• Argentina Market Analysis (USD MN)
• Peru Market Analysis (USD MN)
• Chile Market Analysis (USD MN)
• Rest of Latin America Market Analysis (USD MN)
• Middle East & Africa Market Analysis (USD MN)
• Saudi Arabia Market Analysis (USD MN)
• UAE Market Analysis (USD MN)
• Israel Market Analysis (USD MN)
• South Africa Market Analysis (USD MN)
• Rest of Middle East and Africa Market Analysis (USD MN)
• Partnership/Collaboration/Agreement
• Mergers and Acquisiton

LIST OF FIGURES

• Research Scope of Lysosomal Acid Lipase Report
• Market Research Process
• Market Research Methodology
• Global Lysosomal Acid Lipase Market Size, by Region (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis by Indication
• Market Attractiveness Analysis by Treatment Class
• Market Attractiveness Analysis by Region
• Value Chain Analysis
• Global Market Analysis by Indication (USD MN)
• Wolman Disease (WD) Market by Geography (USD MN)
• Cholesteryl Ester Storage Disease (CESD) Market by Geography (USD MN)
• Global Market Analysis by Treatment Class (USD MN)
• Enzyme Replacement Therapy Market by Geography (USD MN)
• Lipid-Modifying Agents (Statins) Market by Geography (USD MN)
• Surgery (Liver Transplant) Market by Geography (USD MN)
• Stem Cell Transplantation Market by Geography (USD MN)
• Supportive Care Market by Geography (USD MN)
• Global Market by Revenue
• North America Market by Revenue
• Europe Market by Revenue
• Asia Pacific Market by Revenue
• Latin America Market by Revenue
• Middle East & Africa Market by Revenue
• Recent Development in Industry
• Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.